NCT06696456View on ClinicalTrials.gov

Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy

Enrolling by invitationOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

April 30, 2033

Study Completion Date

April 30, 2033

Conditions
Otoferlin Gene-mediated Hearing Loss
Trial Locations (4)

19146

Children's Hospital of Philadelphia, Philadelphia

52242

University of Iowa, Iowa City

08950

Hospital Sant Joan de Déu, Esplugues de Llobregat

(R.O.C), 100

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Akouos, Inc.

INDUSTRY